Dishman Carbogen Amcis Limited
DCAL
Rank in Stocks
#15171
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen... Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited provides specialized contract research and manufacturing solutions to the worldwide pharmaceutical sector. The company operates through two main business segments: Contract Research and Manufacturing Services (CR&MS), and Marketable Molecules. Beyond its core services, it manufactures and distributes an extensive portfolio of products, including bulk drugs, chemical intermediates, various phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D derivatives, and fine chemicals. Additionally, its offerings encompass personal care products like hand and body washes, sanitizers, and antiseptics, as well as a range of pharmaceutical and cosmetic formulations, including generic and highly potent active pharmaceutical ingredients. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Share Price
$1.78
Last synced: 2026-11-09
Market Cap
$278.86M
Change (1 day)
7.26%
Change (1 year)
-36.24%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Dishman Carbogen Amcis Limited (DCAL)
Category
Healthcare
Operating Margin for Dishman Carbogen Amcis Limited (DCAL)
Operating Margin as of November 2026 TTM: 7.12%
According to Dishman Carbogen Amcis Limited's latest financial reports, its current operating margin (TTM) is 7.12%. At the end of 2025 the company had an operating margin of 6.46%.
Operating Margin history for Dishman Carbogen Amcis Limited from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 7.12% | 10.22% |
| 2025 | 6.46% | -310.42% |
| 2024 | -3.07% | -167.32% |
| 2023 | 4.56% | 228.06% |
| 2022 | 1.39% | -313.85% |
| 2021 | -0.65% | -105.70% |
| 2020 | 11.41% | -34.73% |
| 2019 | 17.48% | 14.92% |
| 2018 | 15.21% | 5.26% |
| 2017 | 14.45% | -23.75% |
| 2016 | 18.95% | 72.43% |
| 2015 | 10.99% | -33.35% |
| 2014 | 16.49% | -0.48% |
| 2013 | 16.57% | 22.74% |
| 2012 | 13.50% | 3.61% |
| 2011 | 13.03% | -30.36% |
| 2010 | 18.71% | 0.59% |
| 2009 | 18.60% | 41.34% |
| 2008 | 13.16% | -14.27% |
| 2007 | 15.35% | -19.25% |
| 2006 | 19.01% | -16.59% |
| 2005 | 22.79% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -94.58% |
US
|
|
| -149.01% | -120.93% |
US
|
|
| 25.57% | -96.41% |
AU
|
|
| 31.23% | -95.61% |
BE
|
|
| 29.35% | -95.88% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Dishman Carbogen Amcis Limited's operating margin
What is Dishman Carbogen Amcis Limited's operating margin?
Dishman Carbogen Amcis Limited's operating margin is 7.12%, as of Nov 2026.
What was Dishman Carbogen Amcis Limited's operating margin in 2025?
In 2025, Dishman Carbogen Amcis Limited's operating margin was 6.46%, compared with -3.07% in 2024.
How has Dishman Carbogen Amcis Limited's operating margin changed since 2020?
From 2020 to 2025, Dishman Carbogen Amcis Limited's operating margin was highest in 2020 (11.41%) and lowest in 2024 (-3.07%).
How does Dishman Carbogen Amcis Limited's operating margin compare with similar companies?
Dishman Carbogen Amcis Limited's operating margin (7.12%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.